drugset / Trial / NCT07263698

Investigation of Clinical Efficacy of a New Mouthwash on Reducing Dental Plaque and Helping Prevent Gum Problems as Compared to a Control Mouthwash

NCT07263698

Phase 3 Completed 80 enrolled Colgate Palmolive
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Qualified subjects will be enrolled and randomized to either one of the two study groups described above based on their initial modified gingivitis and plaque scores. Subjects will be instructed to use the products according to the instructions provided. Subjects will return to the dental office for evaluation after two weeks, six weeks and three months of product use. All subjects will be followed for adverse events throughout the study

Timeline

Start
2025-12-01
Primary completion
2026-02-27
Completion
2026-02-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Cetylpyridinium Small molecule 0.09 %
Subject Zinc Lactate Unknown 0.28 %
Comparator sodium fluoride Unknown 100 ppm
Comparator sodium fluoride Unknown 500 ppm

Indications